You are here: Industry Insights > opioid

News List

Purdue defends against opioid lawsuits by pointing to FDA regulations it helped create fiercepharma
July 17, 2018
Purdue is defending itself against lawsuits around the country alleging it downplayed opioid risks and overstated their benefits.
FDA wants social media giants to help crack down on illegal opioid marketers biospectrumasia
June 08, 2018
The FDA’s latest crackdown targets pharmacies hawking illegal opioids online. The agency issued warning letters this week to nine online pharmacies that run 53 websites selling drugs with suspect monikers like “Roxycodone” and “Tramadol Generic.”
Los Angeles becomes latest US city to sue pharma over opioid crisis pharmafile
May 07, 2018
The city of Los Angeles has levied legal action against a number of pharmaceutical firms for their role in advancing the ongoing US opioid crisis, with the filing accusing them of “borrowing from the tobacco industry’s playbook”.
IQVIA™ Institute for Human Data Science Study: U.S. Prescription Opioid Volume Declined 12 Percent in 2017 – Largest Drop in 25 Years biospace
April 20, 2018
The latest report from the IQVIA™ Institute for Human Data Science found prescription opioid dosage volume
The Growing Legal Battles Against Opioid Manufacturers biospace
April 19, 2018
Utah’s Salt Lake County is the latest governing body to enter the legal battle against opioid manufacturers, distributors and prescribers.
Aleafia steps-up battle against opioid crisis biospectrumasia
April 08, 2018
Aleafia launches new opiate-replacement program; hits the gas on 1,000-patient opioid-reduction study.
Aleafia steps-up battle against opioid crisis biospectrumasia
April 08, 2018
Aleafia launches new opiate-replacement program; hits the gas on 1,000-patient opioid-reduction study.
Opioid analgesics reduce the use of antipsychotics in Alzheimer’s disease europeanpharmaceuticalreview
March 30, 2018
Initiating an opioid analgesic reduced the use of antipsychotics and benzodiazepines in persons with Alzheimer’s disease…
Cigna's Partnership with Physicians Successfully Reduces Opioid Use by 25 Percent – One Year Ahead of Goal biospace
March 29, 2018
CIGNA, Inc. (NYSE: CI) today announced that Global Health Services has partnered with more than 1.1 million prescription clinicians to reduce their use of opioids by 25% in their customers
Heron soars after its painkiller agent reduces pain and opioid use post-surgery at Phase 3 pharmafile
March 21, 2018
Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary endpoints in Phase 3 studies

Previous page 1 2 3 4 5 6 7 8 9 10 ... 21 22 Next page